Selected publications

Flückiger U., Marchetti O., Bille J., Eggimann P., Zimmerli S., Imhof A., Garbino J., Ruef C., Pittet D., Glauser M., Calandra T. for the Fungal Infection Network of Switzerland (FUNGINOS).Treatment options of invasive fungal infections in adults.Swiss Medical Weekly 2006, 136:447-463 (IF 1.9).

Marchetti O., Cordonnier C., Calandra T. for the European Conference on Infections in Leukemia (a joint project of the European Organization for Research and Treatment of Cancer (EORTC)-Infectious Diseases Group (IDG), European Bone Marrow Transplantation (EBMT)-Infectious Diseases Working Party (IDWP), European Leukemia Net (ELN)-supportive Care Working Group and of the International Immunocompromised Host Society (ICHS). Empirical antifungal therapy in neutropenic cancer patients with persistent fever: guidelines from the First European conference on infections in leukemia (ECIL-1). European Journal of Cancer 2007, Supplement 5:32-42 (IF 5.0)

Marchetti O., Lamoth F., Mikulska M., Viscoli C., Verweij P., Bretagne S. and the European Conference on Infections in Leukemia (ECIL) Laboratory Working Groups. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemia patient and hematopoietic stem cell transplant recipients. Bone Marrow Transplantation 2012, 47:846-854 (IF 3.7)

Lamoth F., Cruciani M., Mengoli E., Castagnola E., Lortholary O., Richardson M., Marchetti O. on behalf of the Third European Conference on Infections in Leukemia (ECIL-3). Beta-glucan antigenemia for the diagnosis of invasive fungal infections in patients with hematological malignancies: A systematic review and meta-analysis of Cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clinical Infectious Diseases 2012, 54:633-643 (IF 9.2)

Pascual A., Csajika C., Buclin T., Bolay S., Bille J., Calandra T. and Marchetti O. Challenging recommended oral and intraveinous Voriconazole doses for improved efficacy and safety: Population pharmacokinetics-based analysis in adult patients with invasive fungal infections.Clinical Infectious Diseases 2012, 55:381-90 (IF 9.2)

Kern W.V., Marchetti O., Drgona L., Akan H., Aoun M., Akova M., de Bock R., Paesmans M., Viscoli C., Calandra T. and the EORTC-IDG Trial XV Investigators. Oral antibiotics for fever in low-risk neutropenic cancer patients: A double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy (European Organization for Research and Treatment of Cancer Protocol 46001, Infections Diseases Group Trial XV). Journal of Clinical Oncology 2013, 31:1149-1156 (IF 18.4)

Tissot F., Lamoth F., Hauser P.M., Orasch C., Flückiger U., Siegemund M., Zimmerli S., Calandra T., Bille J., Eggimann P., Marchetti O. and the Fungal Infection Network of Switzerland (FUNGINOS). Beta-glucan antigenemia anticipates diagnosis of blood culture-negative intra-abdominal candidiasis. American Journal of Respiratora and Critical Care Medicine 2013, Epud ahead of print